AR051236A1 - Metabolitos glucuronidos de tigeciclina y epimeros de los mismos - Google Patents

Metabolitos glucuronidos de tigeciclina y epimeros de los mismos

Info

Publication number
AR051236A1
AR051236A1 ARP050104639A ARP050104639A AR051236A1 AR 051236 A1 AR051236 A1 AR 051236A1 AR P050104639 A ARP050104639 A AR P050104639A AR P050104639 A ARP050104639 A AR P050104639A AR 051236 A1 AR051236 A1 AR 051236A1
Authority
AR
Argentina
Prior art keywords
tigecycline
tigecicline
glucuronid
metabolites
same
Prior art date
Application number
ARP050104639A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR051236A1 publication Critical patent/AR051236A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

Reivindicacion 1: Un metabolito glucuronido de tigeciclina preparado mediante el tratamiento de seres humanos con tigeciclina. Reivindicacion 7: Un proceso para preparar un metabolito glucuronido de tigeciclina que comprende los pasos de: a) proveer una dosis de tigeciclina a un ser humano; b) obtener una muestra de suero, orina o heces de dicho ser humano; y c) extraer dicha muestra para obtener un metabolito glucuronido de tigeciclina. Reivindicacion 11: Un compuesto seleccionado de las formulas (1) a (4).
ARP050104639A 2004-11-05 2005-11-04 Metabolitos glucuronidos de tigeciclina y epimeros de los mismos AR051236A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62512104P 2004-11-05 2004-11-05

Publications (1)

Publication Number Publication Date
AR051236A1 true AR051236A1 (es) 2006-12-27

Family

ID=36337018

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104639A AR051236A1 (es) 2004-11-05 2005-11-04 Metabolitos glucuronidos de tigeciclina y epimeros de los mismos

Country Status (22)

Country Link
US (1) US7534766B2 (es)
EP (1) EP1807441A2 (es)
JP (1) JP2008519038A (es)
KR (1) KR20070085761A (es)
CN (1) CN101132799A (es)
AR (1) AR051236A1 (es)
AU (1) AU2005304957A1 (es)
BR (1) BRPI0517715A (es)
CA (1) CA2586245A1 (es)
CR (1) CR9111A (es)
GT (1) GT200500320A (es)
HN (1) HN2005030775A (es)
IL (1) IL182640A0 (es)
MX (1) MX2007005105A (es)
NO (1) NO20072226L (es)
PA (1) PA8652001A1 (es)
PE (1) PE20061048A1 (es)
RU (1) RU2007116800A (es)
SV (1) SV2006002294A (es)
TW (1) TW200628485A (es)
WO (1) WO2006052717A2 (es)
ZA (1) ZA200703624B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801936B (zh) * 2007-07-31 2012-10-03 吉利德科罗拉多公司 安立生坦的代谢物和衍生物
US8766177B2 (en) * 2010-10-11 2014-07-01 University Of North Texas Nanomanipulation coupled nanospray mass spectrometry (NMS)
JP6134191B2 (ja) 2013-04-07 2017-05-24 村川 惠美 回転型セミバッチald装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122006000058I1 (de) 1991-10-04 2007-01-18 Wyeth Corp 7-Substituierte-9-substituierte Amino-6-Demethyl-6-Deoxy-Tetracycline
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
SG47520A1 (en) 1992-08-13 1998-04-17 American Cyanamid Co New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
US5328902A (en) 1992-08-13 1994-07-12 American Cyanamid Co. 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5420272A (en) 1992-08-13 1995-05-30 American Cyanamid Company 7-(substituted)-8-(substituted)-9-](substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines
US5284963A (en) 1992-08-13 1994-02-08 American Cyanamid Company Method of producing 7-(substituted)-9-[(substituted glycyl)-amidol]-6-demethyl-6-deoxytetra-cyclines
EA201001081A1 (ru) 2003-07-09 2011-02-28 Пэрэтек Фамэсьютикэлс, Инк. Соединения тетрациклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния у субъекта
AU2004259661B2 (en) 2003-07-09 2011-11-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20050148553A1 (en) 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis

Also Published As

Publication number Publication date
PE20061048A1 (es) 2006-11-15
MX2007005105A (es) 2007-06-26
ZA200703624B (en) 2009-10-28
WO2006052717A2 (en) 2006-05-18
CR9111A (es) 2008-01-21
CA2586245A1 (en) 2006-05-18
AU2005304957A1 (en) 2006-05-18
US7534766B2 (en) 2009-05-19
RU2007116800A (ru) 2008-12-10
EP1807441A2 (en) 2007-07-18
IL182640A0 (en) 2007-07-24
TW200628485A (en) 2006-08-16
WO2006052717A3 (en) 2007-11-15
GT200500320A (es) 2006-06-02
KR20070085761A (ko) 2007-08-27
JP2008519038A (ja) 2008-06-05
NO20072226L (no) 2007-06-04
CN101132799A (zh) 2008-02-27
PA8652001A1 (es) 2006-10-13
US20060128950A1 (en) 2006-06-15
BRPI0517715A (pt) 2008-10-21
SV2006002294A (es) 2006-10-13
HN2005030775A (es) 2006-12-18

Similar Documents

Publication Publication Date Title
AR062841A1 (es) Tratamiento del dolor, diabetes, y trastornos del metabolismo de los lipidos
UY29283A1 (es) Anticuerpos ab(beta)usados en mejorar la cognicion
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
NO20085004L (no) Radioaktivt merkede dihydrotetrabenazinderivater og deres anvendelse som avbildningsmidler
CR8402A (es) Indazol-o-glucosidos sustitutos
AR052238A1 (es) Formulacion de tabletas estables
ECSP099529A (es) Inhibidores de cinasa mapk/erk
ECSP077336A (es) Control de parásitos en animales mediante el uso de nuevos derivados de trifluorometansulfonanilida oxima éter
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
BRPI0416881A (pt) método para reduzir odor excrementos de um animal doméstico.
UY28572A1 (es) Compuestos novedosos
BRPI0515684A (pt) formulações de cristais injetáveis ativas de longa duração de metabólitos de estradiol, e métodos de utilização das mesmas
CR10967A (es) Formas polimorficas de 3-(4-amino-1-oxo-1,3 dihidro-isoindol-2-il) piperidina-2,6-diona (divisional exp. 8291)
UY30736A1 (es) Compuestos quimicos 537
UY28870A1 (es) Derivados heterocíclicos, composiciones y proceso de preparación
AR109263A2 (es) Composición que comprende moxidectina
UY29648A1 (es) Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
ECSP12007431A (es) Compuestos orgánicos
UY30187A1 (es) Nuevas modificaciones cristalinas y solvato
UY29109A1 (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios
CR6766A (es) Metabolitos agonistas/ antagonistas de estrogeno
AR051236A1 (es) Metabolitos glucuronidos de tigeciclina y epimeros de los mismos
UY31522A1 (es) Nanoparticulas con superficie modificada

Legal Events

Date Code Title Description
FB Suspension of granting procedure